SCHEMBL9046207

SCHEMBL9046207

Clc1cccc(-c2c(Cl)ncnc2Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 5/20 0.50
▸ MAP4K4 O95819 4/20 0.49
▸ KMO O15229 1/20 0.47
▸ ALOX5 P09917 1/20 0.47
▸ EGLN2 Q96KS0 1/20 0.45
▸ IKBKE Q14164 1/20 0.45
▸ NOTUM Q6P988 2/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ NFKB1 P19838 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ NFKB2 Q00653 1/20 0.43
▸ RELA Q04206 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ DHFR P00374 1/20 0.42
▸ SCN2A Q99250 1/20 0.42
▸ ADK P55263 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3257778 0.78 PDE4A (0.46) SMN1; SMN2
SCHEMBL17273305 0.77 KMO (0.67) IDO1MAP4K4KMOEGLN2NOTUM
SCHEMBL29450669 0.77 KMO (0.67) IDO1MAP4K4KMOEGLN2NOTUM
SCHEMBL22211542 0.76 PTGS1 (0.45) IDO1MAP4K4KMOALOX5EGLN2
SCHEMBL4452902 0.74 ALOX5 (0.45) IDO1ALOX5IKBKENOTUMNPC1
SCHEMBL9048672 0.74 CYP1A2 (0.48) MAP4K4NPC1NFKB1RAB9ANFKB2
SCHEMBL817554 0.74 ALOX5 (0.65) IDO1ALOX5NOTUMNPC1TP53
SCHEMBL31222672 0.74 ALOX5 (0.65) IDO1ALOX5NOTUMNPC1TP53
SCHEMBL9047230 0.73 ALDH1A1 (0.51) IDO1NPC1TSHRRAB9ASMN1; SMN2
SCHEMBL4450693 0.73 ALOX5 (0.48) IDO1ALOX5IKBKENOTUMNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0510526-B1 Use of sulfonamides as drug and new sulfonamides HOFFMANN LA ROCHE (CH) 1996-12-04 — — EP disclosed
US-5270313-A Treatment of circulatory disorders HOFFMANN-LA ROCHE INC. (US) 1993-12-14 — — US disclosed
EP-0510526-A1 Use of sulfonamides as drug and new sulfonamides F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) 1992-10-28 — — EP disclosed
Send feedback